– USA, CA – Second Sight Medical Products, Inc. (NASDAQ: EYES), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the appointments of Dr. Dean Baker, Ph.D. and Alexandra Larson to its Board of Directors.
“We are honored and excited to add these two very talented individuals to our board. have worked with both for many years and know they are the exact blend of talent and experience we need to move this company strongly forward in our mission to cure all forms of blindness,” ” said Board Chairman, Gregg Williams.
Dr. Baker has also been appointed to the Audit Committee of the Board.
About Dr. Dean Baker
Dr. Baker serves on the Board of Directors of Nano Precision Medical and served on the Board of Directors of Advanced Bionics before its sale to Boston Scientific. Also, he was the founding director of the Alfred E. Mann Institute for Biomedical Engineering at USC and served for nine years on the Board of Directors (including serving on compensation, audit, and governance committees) for Semtech, a publicly traded semiconductor company. He currently serves on the Board of Directors for Transonic Imaging, a medical imaging startup. Dr. Baker was also a vice president of Northrop Grumman for 16 years including overseeing a division with $1 billion in annual sales.
Ms. Larson is VP and General Counsel of Williams International, a privately-held designer, and manufacturer in the aerospace and defense industry. Before Williams International, Ms. Larson was Legal Director and Associate General Counsel at Amcor, Corporate Counsel at Compuware Corporation, and an associate at Baker and McKenzie. Ms. Larson has also held positions with the New York Stock Exchange and the United States Department of Justice, Antitrust Division.
About Second Sight Medical Products, Inc.
Second Sight Medical Products, Inc. develops and markets implantable visual prosthetics that are intended to deliver a useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company’s headquarters are in Los Angeles, California.
For more information: https://secondsight.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.